At the end of the experiment 50% of mice treated with α-PD-1/α-PD-L1 monotherapy were tumor-free whereas complete tumor clearance was noted in 100% of mice receiving HDC/α-PD-1/α-PD-L1. This evidence concerns the gene CD274 and neoplasm.